Postural change, gait, and physical function in older adults.

In a more clinical setting, abrupt posture change may be used to determine the presence of orthostatic hypotension, a hemodynamic response with relationships to physical function. Certain gait features and physical function performance are also associated with risk of falling in older adults. However, the extent to which posture change is associated with subsequent gait and physical function has received little attention in the literature. This study aims to determine the effects of posture change on spatiotemporal parameters of gait and Timed Up-and-Go (TUG) performance. METHODS: Forty-two volunteers (age 73.21 ± 6.22 years) participated in the study. A custom Tekscan Strideway (Tekscan, Boston, MA.) gait system was used to measure gait velocity (VEL), cadence (CAD), stride length (SL), and percent of time spent in active propulsion (AP). Dependent t-tests were used to compare TUG time, VEL, CAD, SL and AP after at least 10 mins of seated rest and supine rest. RESULTS: Time to complete the TUG was significantly slower after supine rest compared to seated (11.47 ± 0.51 and 10.01 ± 0.33 s, respectively, p<0.001); VEL was significantly slower after supine rest compared to seated (0.888 ± 0.042 and 1.049 ± 0.033 m/s, respectively, p=0.003); CAD was significantly slower after supine rest compared to seated (111.21 ± 2.87 and 120.97 ± 2.56spm, respectively, p=0.001); and AP was significantly lower after supine rest compared to seated (56.87 ± 4.76 and 70.79 ± 4.05 %, respectively, p<0.001). No significant differences were detected in stride length between conditions. CONCLUSIONS: Among this sample of older adults, standing from a supine posture is associated with spatiotemporal gait parameters consistent with a risk for falling and aging. Additionally, TUG performance worsens significantly after supine rest. Future studies could explore the sensitivity and specificity of falls risk screening after supine rest.

Comparative effectiveness of hysteroscopic and laparoscopic sterilization for women: a retrospective cohort study.

OBJECTIVE: To compare real-world effectiveness of hysteroscopic to laparoscopic sterilization. DESIGN: Retrospective cohort of Medicaid claims for hysteroscopic or laparoscopic sterilization procedures performed in California, 2008-2014. After excluding postpartum procedures, we applied log-linear (Poisson) event-history regression models for clustered person-period data, weighted for propensity to receive either sterilization procedures, and adjusted for sociodemographic and clinical variables to examine the poststerilization pregnancy rates. SETTING: Clinics, hospitals. PATIENT(S): Women aged 18-50 years with Medicaid claims between January 1, 2008, and August 31, 2014. INTERVENTION(S): Hysteroscopic or laparoscopic sterilization procedure. MAIN OUTCOME MEASURE(S): Poststerilization pregnancy measured by pregnancy-related claims. RESULT(S): Among women with hysteroscopic (n = 5,906) or laparoscopic (n = 23,965) sterilization, poststerilization pregnancy claims were identified for 4.74% of women after hysteroscopic sterilization and 5.57% after laparoscopic sterilization. The pregnancy rates decreased over time after either procedure. Twelve months after the procedure, the crude incidence of pregnancy claims was higher for hysteroscopic sterilization than for laparoscopic sterilization (3.26 vs. 2.61 per 100 woman-years), but the propensity-weighted adjusted incidence rate ratio was 1.06 (95% confidence interval [CI], 0.85-1.26). Between 13 and 24 months after the procedure, there were fewer pregnancies for women after hysteroscopic sterilizations than for those after laparoscopic sterilizations (adjusted incidence rate ratio, 0.63 [95% CI, 0.45-0.88]), with no statistically significant differences in later years. The cumulative pregnancy rates 5 years after sterilization were lower with hysteroscopic sterilization than with laparoscopic sterilization (6.26 vs. 7.22 per 100 woman-years; propensity-weighted, adjusted risk ratio, 0.76 [95% CI, 0.62-0.90]). The poststerilization pregnancy rates varied by age and race/ethnicity. CONCLUSION(S): The pregnancy rates after female sterilization are higher than expected, whether performed hysteroscopically or laparoscopically. These findings are reassuring that the effectiveness of hysteroscopic sterilization was not inferior to laparoscopic sterilization. CLINICAL TRIAL REGISTRATION NUMBER: NCT03438682.

Comparative Effectiveness and Safety of Intrauterine Contraception and Tubal Ligation.

BACKGROUND: Tubal ligation remains common in the USA, especially among low-income patients. OBJECTIVE: To compare the effectiveness and safety of intrauterine contraceptives (IUC) to laparoscopic tubal ligation for Medicaid clients. DESIGN: We partnered with patient and clinician stakeholders to conduct a retrospective cohort study using California Medicaid claims for patients who had an IUC placed or laparoscopic tubal ligation performed in 2008-2014, excluding procedures performed within 42 days of a birth. We applied log-linear (Poisson) event-history regression models for clustered person-period data to adjust for sociodemographic variables and pre-procedure health status when examining associations between these contraceptive procedures and claims related to contraceptive failure, complications, and pain in the first year post-procedure. KEY RESULTS: We identified 35,705 patients who had a levonorgestrel IUC placed, 23,628 patients who had a copper IUC placed, and 23,965 patients who underwent laparoscopic tubal ligation. In unadjusted analyses, rates of pregnancy within 1 year were similar following levonorgestrel IUC (2.40%) or copper IUC placement (2.99%) or tubal ligation (2.64%). In adjusted analyses, compared to tubal ligation, pregnancy was less common following placement of a levonorgestrel IUC (adj IRR 0.72, 95% CI 0.64-0.82) and similar with placement of a copper IUC (adj IRR 0.92, 95% CI 0.82-1.05). Procedural complications such as infection (0.35% vs. 2.91%) were significantly less common with IUC placement than tubal ligation. Claims for pelvic and abdominal pain decreased in frequency with time since all procedures; 6 to 12 months post-procedure, pelvic pain claims were less common after levonorgestrel IUC (adj IRR 0.69, 95% CI 0.65-0.73) or copper IUC placement (adj IRR 0.70, 95% CI 0.66-0.75) than tubal ligation. CONCLUSIONS: IUC appears at least as effective as laparoscopic tubal ligation at 1-year post-procedure with lower rates of infection and pelvic pain 6 to 12 months post-procedure. CLINICAL TRIAL REGISTRATION: NCT03438682.

Patient-Centered Safety Outcomes After Hysteroscopic Compared With Laparoscopic Sterilization.

OBJECTIVE: To evaluate the real-world safety of hysteroscopic compared with laparoscopic surgical sterilization. METHODS: We conducted a retrospective cohort study of Medicaid claims for hysteroscopic or laparoscopic sterilization procedures performed in California, 2008-2014, among women aged 18-50 years. After excluding postpartum procedures, we applied log-linear (Poisson) event-history regression models for clustered person-period data, weighted for propensity to receive either sterilization procedures, and adjusted for sociodemographic and clinical characteristics that may affect outcomes of interest to patients and physicians. We assessed the following outcomes: procedural complications, additional surgical procedures (eg, hysterectomy), repeat sterilization procedures, pelvic pain, pelvic inflammatory disease (PID), abdominal pain, nonabdominal pain, and abnormal uterine bleeding. RESULTS: We identified 5,906 women who had undergone hysteroscopic and 23,965 who had undergone laparoscopic sterilization. After adjusting for sociodemographic and health history, women who had hysteroscopic sterilization were less likely to have claims for procedural complications (eg, transfusion, P<.001) on the day of surgical sterilization and additional surgical procedures (eg, hysterectomy, P=.002 at day 2-3 months postprocedure) than laparoscopic sterilization. Claims for a repeat attempt at sterilization were more common after hysteroscopic sterilization within 1 year (adjusted incident rate ratio 3.48, 95% CI 2.69-4.27) and within 5 years (adjusted incident rate ratio 2.32, 95% CI 1.84-2.79) than laparoscopic sterilization. Claims for pelvic pain (adjusted incident rate ratio 0.77, 95% CI 0.65-0.92 at 2 years), abdominal pain (adjusted incident rate ratio 0.80, 95% CI 0.68-0.93 at 7-12 months), and PID (adjusted incident rate ratio 0.55, 95% CI 0.33-0.93 at 2 years) were less common after hysteroscopic than laparoscopic sterilization. Although abnormal uterine bleeding claims were more common after hysteroscopic than laparoscopic sterilization up to 12 months postprocedure (adjusted incident rate ratio 1.37, 95% CI 1.06-1.77 at 7-12 months), there were no significant differences between methods 1 year after the procedure. CONCLUSION: Compared with laparoscopic sterilization, hysteroscopic sterilization was followed by more claims for repeat sterilization procedures and abnormal uterine bleeding, but fewer procedural complications and fewer claims for pelvic or abdominal pain. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT03438682.

Using Prescription Drug Monitoring Program Data to Assess Likelihood of Incident Long-Term Opioid Use: a Statewide Cohort Study.

BACKGROUND: Limiting the incidence of opioid-naïve patients who transition to long-term opioid use (i.e., continual use for > 90 days) is a key strategy for reducing opioid-related harms. OBJECTIVE: To identify variables constructed from data routinely collected by prescription drug monitoring programs that are associated with opioid-naïve patients' likelihood of transitioning to long-term use after an initial opioid prescription. DESIGN: Statewide cohort study using prescription drug monitoring program data PARTICIPANTS: All opioid-naïve patients in California (no opioid prescriptions within the prior 2 years) age ≥ 12 years prescribed an initial oral opioid analgesic from 2010 to 2017. METHODS AND MAIN MEASURES: Multiple logistic regression models using variables constructed from prescription drug monitoring program data through the day of each patient's initial opioid prescription, and, alternatively, data available up to 30 and 60 days after the initial prescription were constructed to identify probability of transition to long-term use. Model fit was determined by the area under the receiver operating characteristic curve (C-statistic). KEY RESULTS: Among 30,569,125 episodes of patients receiving new opioid prescriptions, 1,809,750 (5.9%) resulted in long-term use. Variables with the highest adjusted odds ratios included concurrent benzodiazepine use, ≥ 2 unique prescribers, and receipt of non-pill, non-liquid formulations. C-statistics for the day 0, day 30, and day 60 models were 0.81, 0.88, and 0.94, respectively. Models assessing opioid dose using the number of pills prescribed had greater discriminative capacity than those using milligram morphine equivalents. CONCLUSIONS: Data routinely collected by prescription drug monitoring programs can be used to identify patients who are likely to develop long-term use. Guidelines for new opioid prescriptions based on pill counts may be simpler and more clinically useful than guidelines based on days' supply or milligram morphine equivalents.

Movement direction impacts knee joint kinematics during elliptical exercise at varying incline angles.

BACKGROUND: Elliptical trainers are a popular cardiovascular exercise for individuals with injuries or those post-operation. There is currently limited data on the impacts of direction while on elliptical trainers for knee joint kinematic risk factors. This study compared lower extremity kinematics between the forward and reverse direction at varying inclines on an elliptical trainer modified with converging footpath and reduced inter-pedal distance. METHODS: Twenty-four college age participants exercised on the modified elliptical in both directions at four ramp inclines: 6°, 12°, 25°, and 35°. Three-dimensional kinematics were collected for each direction and ramp incline. A 2 × 4 (direction × incline) repeated measures analysis of variance was run with an alpha of 0.05. Simple effects analysis was run with Bonferroni correction for significant interaction or main effect of ramp incline. RESULTS: The reverse direction had significantly greater peak knee valgus at 6° incline (mean difference [MD] = 1.35°, p < 0.014, d = 0.31) and 12° (MD = 2.41°, p < 0.001, d = 0.55), peak hip abduction at 6° (MD = 2.86°, p = 0.002, d = 0.49) and 12° (MD = 2.91°, p < 0.001, d = 0.51), but decreased peak knee flexion angles (p = 0.032) at all inclines. CONCLUSIONS: Individuals with knee pathologies such as knee osteoarthritis or anterior knee pain should exercise in the reverse direction at lower inclines. However, switching to the forward direction and/or increasing incline may increase quadriceps strength during a safe activity such as elliptical trainers.

The effects of a standard elliptical vs. a modified elliptical with a converging footpath on lower limb kinematics and muscle activity.

Elliptical trainers that increase the inter-pedal distance may have potential benefits for knee osteoarthritis by decreasing the amount of knee varus. Modifying elliptical trainers with a converging footpath and reduced inter-pedal distance may be beneficial for reducing anterior knee pathology risk by decreasing knee valgus angles. Twenty-one college students participated in a single testing session. Participants exercised on two different elliptical trainers, one modified with a converging footpath and reduced inter-pedal width, and a standard elliptical trainer. Participants exercised for 2 min at three ramps incline at 120 strides per minute and constant work rate. Three-dimensional kinematics and electromyography of the dominant lower limb were recorded. Multiple 2 × 3 (Elliptical x Incline) ANOVAs with Bonferroni corrections were used to compare the two elliptical trainers at each incline for kinematics and muscle activity. The modified elliptical trainer displayed significantly decreased peak knee valgus (p = 0.031, η p 2 = 0.234 ), peak knee flexion (p = 0.006, η p 2 = 0.246 ), and interactions for peak knee flexion (p = 0.001, η p 2 = 0.250 ) and vastus lateralis (p < 0.01, η p 2 = 0.380 ) muscle activity compared to the standard elliptical trainer. The decreased peak knee valgus and flexion angles could be beneficial for reducing long-term injury risk for anterior knee pathologies.

Medication Status and Gait Mechanics in Older Adults: A Multivariate Analysis.

BACKGROUND AND PURPOSE: Falls are the leading cause of unintentional deaths in older adults, with nearly one-third of adults older than 65 years falling annually. Previous work reveals that both medication status and gait changes are contributing factors to falls in older adults; however, it is unknown how these factors interact. Thus, the purpose of this investigation was to examine differences between gait biomechanics as a function of medication status in individuals older than 60 years with a self-reported history of falling. It was hypothesized that differences in gait mechanics would be observed as a function of the number of medications in these individuals. METHODS: A total of 384 participants, age, mean (SD) = 73.2 (4.2) years; height, mean (SD) = 173.09 (16.4) cm; mass, mean (SD) = 65.45 (5.78) kg, were recruited from across the Southwest United States (Texas, New Mexico, Arizona, Nevada, and California) by the Electronic Caregiver Mobile Fall Risk Assessment Laboratory. Data for cadence, gait velocity, stride length, swing time, and double-support time were collected using a Walkway gait analysis system. Factor analysis was employed to determine whether the gait characteristics were similar to those observed in previous studies. A multivariate analysis with a follow-up univariate analysis was employed to determine group differences in gait factors and variables according to medication number (≥4 medications, n = 262 vs ≤3 medications, n = 122). RESULTS: Results of the factor analysis reveal that the data analyzed in the current study are similar to those observed in previous studies, with cadence (factor loading coefficient [FLC] = 0.745), gait velocity (FLC = 0.922), stride length (FLC = 0.789 for left and 0.790 for right) loading positively on a "pace" factor, swing time (FLC = 0.728 for right and 0.683 for left), and double-support time (FLC= 0.723) loading positively on a "rhythm" factor. The results of the multivariate analysis of variance revealed differences in gait factors across groups according to medication status. Univariate follow-up tests reveal that double-support time is longer and stride length is shorter in persons taking 4 or more medications as compared with those on 3 or fewer medications. CONCLUSION: The findings of this study indicate that certain abnormal gait parameters in participants with a history of falls are associated with taking 4 or more medications. Future studies should examine the extent to which gait changes and medications interact to predict falls.